IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
676.04
+5.33 (0.79%)
At close: Nov 6, 2026, 4:00 PM EST
674.42
-1.62 (-0.24%)
After-hours: Nov 6, 2026, 7:59 PM EST
IDEXX Laboratories Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,214 | 1,217 | 1,141 | 1,091 | 1,105 | 1,109 | 998.43 | 954.29 | 975.54 | 1,004 | 964.1 | 901.6 | 915.53 | 943.63 | 900.2 | 828.57 | 841.66 | 860.55 | 836.55 | 801.09 |
Revenue Growth | 9.86% | 9.66% | 14.26% | 14.28% | 13.30% | 10.55% | 3.56% | 5.84% | 6.55% | 6.35% | 7.10% | 8.81% | 8.78% | 9.65% | 7.61% | 3.43% | 3.85% | 4.16% | 7.57% | 11.12% |
Gross Profit Gross Profit Growth | 764.3 | 779.09 | 722.74 | 658.11 | 683.35 | 694.73 | 623.38 | 570.66 | 596.04 | 619.16 | 593.07 | 526.17 | 547.98 | 572.85 | 542.97 | 484.93 | 506.63 | 514.03 | 498.75 | 456.42 |
Operating Income Operating Income Growth | 402.35 | 425.57 | 362.59 | 324.61 | 354.85 | 373.05 | 307.53 | 261.69 | 303.89 | 325.3 | 298.96 | 245.3 | 275.28 | 296.14 | 280.4 | 226.53 | 244.83 | 179.07 | 248.34 | 199.19 |
Net Income Net Income Growth | 317.15 | 338.41 | 278.45 | 248.19 | 274.61 | 293.99 | 242.68 | 216.15 | 232.84 | 203.3 | 235.58 | 194.52 | 212.23 | 224.24 | 214.05 | 172.21 | 180.94 | 131.98 | 193.97 | 162.77 |
Earnings Per Share EPS Growth | 4.01 | 4.27 | 3.47 | 3.09 | 3.40 | 3.63 | 2.96 | 2.62 | 2.80 | 2.44 | 2.81 | 2.31 | 2.53 | 2.67 | 2.55 | 2.06 | 2.15 | 1.56 | 2.27 | 1.89 |
EPS Growth | 17.94% | 17.63% | 17.23% | 17.88% | 21.43% | 48.77% | 5.34% | 13.41% | 10.67% | -8.61% | 10.20% | 12.09% | 17.67% | 71.15% | 12.34% | 9.13% | 5.91% | -33.33% | -3.40% | -6.07% |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
IDEXX VetLab Consumables IDEXX VetLab Consumables Growth | 443.25 | 430.34 | 412.58 | 389.05 | 387.81 | 375.11 | 344.78 | 331.85 | 329.13 | 325.35 | 316.93 | 297.37 | 296.04 | 303.74 | 291.11 | 261.16 | 262.82 | 266.08 | 267.17 | 251.62 |
Rapid Assay Products Rapid Assay Products Growth | 89.14 | 101.58 | 84.94 | 76.04 | 88.64 | 100.24 | 84.03 | 77.38 | 92.77 | 103.29 | 86.32 | 77.56 | 87.56 | 97.34 | 82.03 | 71.13 | 80.54 | 87.48 | 74.52 | 66.38 |
Reference Laboratory Diagnostic & Consulting Reference Laboratory Diagnostic & Consulting Growth | 399.08 | 406.73 | 386.18 | 349.25 | 362.73 | 367.69 | 344.41 | 316.03 | 328.38 | 347.37 | 344.34 | 305.04 | 320.29 | 330.11 | 323.18 | 283.32 | 295.59 | 304.13 | 295.08 | 271.9 |
CAG Diagnostics Services & Accessories CAG Diagnostics Services & Accessories Growth | 35.89 | 36.07 | 36.61 | 35.33 | 34.1 | 34.95 | 33.05 | 32.2 | 33.16 | 32.44 | 32.56 | 32.12 | 30.06 | 31.3 | 30.58 | 27.14 | 28.36 | 27.72 | 28.04 | 27.72 |
CAG Diagnostics Capital - Instruments CAG Diagnostics Capital - Instruments Growth | 51.49 | 47.17 | 42.45 | 58.13 | 51.48 | 58.6 | 31.99 | 33.02 | 29.53 | 35.29 | 34.09 | 38.15 | 32.25 | 34.05 | 33.14 | 38.93 | 35.18 | 36.23 | 37 | 43.5 |
Veterinary Software, Services & Diagnostics Veterinary Software, Services & Diagnostics Growth | 97.13 | 96.35 | 91.29 | 90.68 | 87.78 | 85.85 | 81.58 | 80 | 79.02 | 78.55 | 75.05 | 71.03 | 70.95 | 70.12 | 67.23 | 66.86 | 62.51 | 62.45 | 59.38 | 57.98 |
Water Segment Water Segment Growth | 58.84 | 58.56 | 50.27 | 50.53 | 54.3 | 51 | 45.32 | 45.15 | 50.16 | 46.73 | 43.07 | 41.79 | 44.45 | 43.03 | 38.88 | 39.31 | 40.48 | 39.2 | 36.37 | 37.14 |
LPD Segment LPD Segment Growth | 34.83 | 35.18 | 32.48 | 37.49 | 33.94 | 31.76 | 28.6 | 34.56 | 28.99 | 30.31 | 28.21 | 32.79 | 29.75 | 29.91 | 29.21 | 33.4 | 28.45 | 29.89 | 30.87 | 33.97 |
Other Other Growth | 4.61 | 4.6 | 4.02 | 4.09 | 4.46 | 4.25 | 4.67 | 4.11 | 4.4 | 4.25 | 3.53 | 5.76 | 4.17 | 4.04 | 4.83 | 7.33 | 7.38 | 7.38 | 8.12 | 10.89 |
Revenue (Total) Revenue (Total) Growth | 1,214 | 1,217 | 1,141 | 1,091 | 1,105 | 1,109 | 998.43 | 954.29 | 975.54 | 1,004 | 964.1 | 901.6 | 915.53 | 943.63 | 900.2 | 828.57 | 841.66 | 860.55 | 836.55 | 801.09 |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 197.54 | 196.93 | 200.53 | 180.07 | 208.17 | 164.59 | 163.97 | 288.27 | 308.64 | 401.59 | 397.43 | 453.93 | 331.7 | 132.84 | 111.37 | 112.55 | 99.18 | 114.36 | 204.62 | 144.45 |
Total Debt Total Debt Growth | 972.96 | 1,096 | 1,105 | 976.51 | 1,113 | 1,237 | 1,059 | 986.95 | 998.28 | 1,068 | 1,069 | 1,067 | 1,141 | 1,156 | 1,320 | 1,470 | 1,506 | 1,497 | 1,284 | 1,031 |
Net Cash (Debt) Net Cash Growth | -775.43 | -899.15 | -904.92 | -796.44 | -904.8 | -1,073 | -895.39 | -698.68 | -689.64 | -666.29 | -671.51 | -613.42 | -808.88 | -1,023 | -1,209 | -1,357 | -1,407 | -1,382 | -1,079 | -886.56 |
Net Cash Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -9.81 | -11.34 | -11.29 | -9.90 | -11.22 | -13.24 | -10.93 | -8.46 | -8.30 | -7.99 | -8.00 | -7.31 | -9.63 | -12.18 | -14.40 | -16.20 | -16.73 | -16.29 | -12.61 | -10.29 |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 449.72 | 347.16 | 266.25 | 355.76 | 402.34 | 185.74 | 237.96 | 262.03 | 220.08 | 248.31 | 198.59 | 249.85 | 272.43 | 200.31 | 183.91 | 173.43 | 189 | 65.85 | 114.71 | 209.96 |
Capital Expenditures CapEx Growth | -28.93 | -24.65 | -31.98 | -29.43 | -31.11 | -34.1 | -30.03 | -29.26 | -28.09 | -33.31 | -30.27 | -32.56 | -34.09 | -27.47 | -39.51 | -49.23 | -37.69 | -30.09 | -31.84 | -31.79 |
Free Cash Flow Free Cash Flow Growth | 420.79 | 322.52 | 234.26 | 326.33 | 371.23 | 151.64 | 207.94 | 232.77 | 191.99 | 215.01 | 168.31 | 217.3 | 238.34 | 172.84 | 144.4 | 124.2 | 151.32 | 35.76 | 82.87 | 178.18 |
Free Cash Flow Growth | 13.35% | 112.68% | 12.66% | 40.19% | 93.36% | -29.47% | 23.54% | 7.12% | -19.45% | 24.39% | 16.56% | 74.96% | 57.51% | 383.29% | 74.25% | -30.29% | 6.42% | -83.08% | -20.52% | -12.98% |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 62.94% | 64.04% | 63.35% | 60.35% | 61.83% | 62.62% | 62.44% | 59.80% | 61.10% | 61.70% | 61.52% | 58.36% | 59.85% | 60.71% | 60.32% | 58.53% | 60.19% | 59.73% | 59.62% | 56.97% |
Operating Margin | 33.14% | 34.98% | 31.78% | 29.76% | 32.11% | 33.62% | 30.80% | 27.42% | 31.15% | 32.41% | 31.01% | 27.21% | 30.07% | 31.38% | 31.15% | 27.34% | 29.09% | 20.81% | 29.69% | 24.87% |
Pretax Margin | 32.89% | 34.29% | 31.16% | 28.15% | 31.19% | 32.66% | 31.06% | 26.87% | 30.64% | 25.81% | 30.65% | 26.58% | 29.26% | 30.30% | 29.74% | 25.73% | 27.82% | 19.88% | 28.87% | 23.95% |
Profit Margin | 26.12% | 27.82% | 24.41% | 22.76% | 24.85% | 26.50% | 24.31% | 22.65% | 23.87% | 20.26% | 24.44% | 21.57% | 23.18% | 23.76% | 23.78% | 20.78% | 21.50% | 15.34% | 23.19% | 20.32% |
FCF Margin | 34.65% | 26.51% | 20.54% | 29.92% | 33.59% | 13.67% | 20.83% | 24.39% | 19.68% | 21.42% | 17.46% | 24.10% | 26.03% | 18.32% | 16.04% | 14.99% | 17.98% | 4.16% | 9.91% | 22.24% |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 34.80 | 36.44 | 40.75 | 50.99 | 49.75 | 43.76 | 38.03 | 38.13 | 48.00 | 47.58 | 51.75 | 54.55 | 44.12 | 52.67 | 59.35 | 49.75 | 40.51 | 44.38 | 62.72 | 74.96 |
Forward PE | 33.36 | 34.96 | 38.70 | 48.03 | 48.34 | 42.95 | 35.08 | 35.35 | 44.12 | 42.80 | 48.50 | 51.93 | 42.03 | 50.49 | 52.20 | 44.25 | 36.34 | 41.35 | 57.92 | 73.77 |
P/FCF Ratio | 31.55 | 33.11 | 41.19 | 51.10 | 53.05 | 54.99 | 40.15 | 41.90 | 52.46 | 47.96 | 56.28 | 59.64 | 53.40 | 70.33 | 91.06 | 85.72 | 60.53 | 67.12 | 74.96 | 87.79 |
PS Ratio | 8.82 | 9.12 | 10.04 | 12.55 | 12.27 | 10.68 | 8.66 | 8.69 | 10.82 | 10.63 | 12.04 | 12.59 | 10.12 | 11.86 | 12.09 | 10.03 | 8.12 | 8.90 | 14.07 | 17.36 |